Health & Safety

July 9, 2012

Neurotrauma, Psychological Health office partners with VA to study PTSD treatments

by Carey Phillips
Fort Detrick, Md.

Post-traumatic stress disorder is a common anxiety disorder that can stem from any traumatic event experienced by an individual.

While there are medications currently approved by the U.S. Food and Drug Administration to treat it, they are not sufficiently effective in treating combat-related post-traumatic stress commonly seen in service members and veterans.

The U.S. Army Medical Materiel Development Activity’s Neurotrauma and Psychological Health Project Management Office signed an interagency agreement with the Veterans Affairs Cooperative Studies Program, or VACSP, to jointly conduct and support clinical studies of pharmacotherapeutics for the treatment of combat-related Post-traumatic stress disorder, knowns as PTSD, in service members and veterans.

“The interagency agreement between USAMMDA and VACSP structures how the agencies will collaborate,” said Maj. Gary Wynn, research psychiatrist with the Neurotrauma and Psychological Health Project Management Office. “While the DOD may be funding the research effort, the VA is an equal partner in the project.”

“The VA is the primary location for Veterans to receive care so we need to be looking at their populations as well as those still on active duty,” he explained.

USAMMDA and VACSP will be working together to identify and develop alternate indications for existing FDA-approved drugs used to treat other disorders.

“While these drugs are FDA-approved, they are not approved for the treatment of PTSD,” said Wynn. “In fact, many of the drugs currently being used have little, or no research supporting their off-label use in treating PTSD.”

Currently, there are two drugs that are FDA-approved for treating PTSD. However, studies have shown that these drugs are less than 50 percent effective when it comes to treating combat-related PTSD. Additionally, the side effects from these drugs can be harmful to service members and veterans.

Although these drugs have helped victims of PTSD, worldwide they have shown limited benefit for service members and veterans struggling with the aftermath of combat.

“These studies are vital to understand if and how [the drugs in the collaborative USAMMDA and VACSP study] should be used in service members and veterans,” said Wynn.

According to Wynn, the collaboration between USAMMDA and the VA will ensure the highest quality of research.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines February 25, 2015

News: Army to send headquarters group to Kandahar in first sign of revision to Afghan withdrawal plan - In the first official sign that the Pentagon plans to keep a U.S. military presence in southern Afghanistan after this year, the Army is sending the 7th Infantry Division headquarters from Joint Base Lewis-McChord on a year-long deployment...
 
 

News Briefs February 25, 2015

Lithuania restores compulsory military service Lithuania will restore compulsory military service for young men as tensions in Ukraine continue to worry the small Baltic nation, the government said Feb. 24. After a meeting of military leaders and top government officials, President Dalia Grybauskaite said the measure was necessary because of growing aggression in Ukraine. Military...
 
 
Sensor Concepts Inc. photograph

Air Force Research Labís handheld imaging tool expands aircraft inspection capability

Sensor Concepts Inc. photograph An operator demonstrates the portability of the handheld imaging tool. The technology provides maintainers the ability to evaluate aircraft in the field to ensure mission-readiness. When pilots c...
 

 

Boeing, Royal Australian Air Force test extended range weapon

The Boeing Joint Direct Attack Munition Extended Range demonstrated significant range increase while maintaining its expected accuracy during flight testing conducted by Boeing and the Royal Australian Air Force. The testing centered on a new wing kit that, when used in conjunction with the weaponís guidance kit, increases the bomb’s range from approximately 15 miles...
 
 

DRS Technologies to provide comm systems for Royal New Zealand Navy frigates

DRS Technologies Inc., a Finmeccanica Company, announced Feb. 25 that its Canadian subsidiary will be providing tactical integrated communications systems to the New Zealand Ministry of Defense for the Royal New Zealand Navy’s ANZAC-class frigates. This subcontract was awarded to DRS Technologies Canada Ltd. in support of a communications modernization contract from Lockheed Martin Canada...
 
 

Northrop Grumman LITENING achieves two million operating hour milestone

In the life cycle of every military system, some milestones stand out as signature achievements. One million operating hours is one of them – and Northrop Grumman’s fielded AN/AAQ-28(V) LITENING pods have hit that number for the second time. “This is a significant milestone for the LITENING program and our team is proud to be...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>